Reducing animals in research: novel platform predicts drug activity in vitro
Wyss Institute (MA, USA) researchers have successfully developed and tested a ‘Body-on-Chips’ platform. By providing data on the behavior of drugs in vitro, could this be the solution to the clinical trial failure rate seen today?
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>